Rybrevant 350 MG/7 ML vial 7ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL9XE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,169
Award facts
- Contract value 100% obligated
- $14,169.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Rybrevant 350 mg/7 ml vials with a ceiling value of $14,169.12 under a firm fixed-price contract. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. The award was not designated as a set-aside contract and was competitively awarded, reflecting AmerisourceBergen's established capability to meet federal procurement requirements.
Performance of this delivery order is to be completed by December 26, 2025, with fulfillment conducted from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves multiple government healthcare customers including the Defense Health Agency, U.S. Coast Guard, and military medical supply chains through its extensive portfolio of pharmaceutical delivery contracts with DLA and related agencies.
Quick answers
Who was awarded contract SPE2DR26FL9XE?
SPE2DR26FL9XE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FL9XE worth?
The government has obligated $14,169 on SPE2DR26FL9XE.
Is contract SPE2DR26FL9XE an order under another contract?
Yes. SPE2DR26FL9XE is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9XE competed?
The extent of competition for SPE2DR26FL9XE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award